Search research articles
Contact Us
Filters
Showing results (211-220 of 242) with videos related to
Page
of 25
Sort By:
Pediatrics
|
August 10, 2016
Schedules for Pneumococcal Vaccination of Preterm Infants: An RCT
Alison Kent, Shamez N Ladhani, Nick J Andrews, et al.
Lancet (London, England)
|
July 2, 2023
Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing
Ratna Wijaya, Marina Johnson, Nicola Campbell, et al.
NPJ Vaccines
|
April 29, 2024
Realising the potential of correlates of protection for vaccine development, licensure and use: short summary
Deborah F King, Helen Groves, Charlie Weller, et al.
The Journal of Infectious Diseases
|
April 11, 2022
Defective Monocyte Enzymatic Function and an Inhibitory Immune Phenotype in Human Immunodeficiency Virus-Exposed Uninfected African Infants in the Era of Antiretroviral Therapy
Louise Afran, Kondwani C Jambo, Wilfred Nedi, et al.
The Lancet. Infectious Diseases
|
January 13, 2019
Comparison of two schedules of two-dose priming with the ten-valent pneumococcal conjugate vaccine in Nepalese children: an open-label, randomised non-inferiority controlled trial
Rama Kandasamy, Meeru Gurung, Stephen Thorson, et al.
Journal of Clinical Microbiology
|
May 15, 2015
Genomics Reveals the Worldwide Distribution of Multidrug-Resistant Serotype 6E Pneumococci
Andries J van Tonder, James E Bray, Lucy Roalfe, et al.
The Lancet. Infectious Diseases
|
January 27, 2019
Serocorrelates of protection against infant group B streptococcus disease
Kirsty Le Doare, Beate Kampmann, Johan Vekemans, et al.
The Journal of Allergy and Clinical Immunology
|
September 24, 2020
Long-term outcomes for adults with chronic granulomatous disease in the United Kingdom
Luiza C Campos, Giulia Di Colo, Vruti Dattani, et al.
Vaccine
|
July 15, 2018
Safety and immunogenicity of the Cuban heptavalent pneumococcal conjugate vaccine in healthy infants. Results from a double-blind randomized control trial Phase I
Carlos P Dotres Martínez, Nivaldo Linares-Pérez, María E Toledo-Romaní, et al.
Journal of Clinical Microbiology
|
May 25, 2016
Correction for van Tonder et al., Genomics Reveals the Worldwide Distribution of Multidrug-Resistant Serotype 6E Pneumococci
Andries J van Tonder, James E Bray, Lucy Roalfe, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 242) with videos related to
Sort By:
Page
of 25
Pediatrics
|
August 10, 2016
Schedules for Pneumococcal Vaccination of Preterm Infants: An RCT
Alison Kent, Shamez N Ladhani, Nick J Andrews, et al.
Lancet (London, England)
|
July 2, 2023
Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing
Ratna Wijaya, Marina Johnson, Nicola Campbell, et al.
NPJ Vaccines
|
April 29, 2024
Realising the potential of correlates of protection for vaccine development, licensure and use: short summary
Deborah F King, Helen Groves, Charlie Weller, et al.
The Journal of Infectious Diseases
|
April 11, 2022
Defective Monocyte Enzymatic Function and an Inhibitory Immune Phenotype in Human Immunodeficiency Virus-Exposed Uninfected African Infants in the Era of Antiretroviral Therapy
Louise Afran, Kondwani C Jambo, Wilfred Nedi, et al.
The Lancet. Infectious Diseases
|
January 13, 2019
Comparison of two schedules of two-dose priming with the ten-valent pneumococcal conjugate vaccine in Nepalese children: an open-label, randomised non-inferiority controlled trial
Rama Kandasamy, Meeru Gurung, Stephen Thorson, et al.
Journal of Clinical Microbiology
|
May 15, 2015
Genomics Reveals the Worldwide Distribution of Multidrug-Resistant Serotype 6E Pneumococci
Andries J van Tonder, James E Bray, Lucy Roalfe, et al.
The Lancet. Infectious Diseases
|
January 27, 2019
Serocorrelates of protection against infant group B streptococcus disease
Kirsty Le Doare, Beate Kampmann, Johan Vekemans, et al.
The Journal of Allergy and Clinical Immunology
|
September 24, 2020
Long-term outcomes for adults with chronic granulomatous disease in the United Kingdom
Luiza C Campos, Giulia Di Colo, Vruti Dattani, et al.
Vaccine
|
July 15, 2018
Safety and immunogenicity of the Cuban heptavalent pneumococcal conjugate vaccine in healthy infants. Results from a double-blind randomized control trial Phase I
Carlos P Dotres Martínez, Nivaldo Linares-Pérez, María E Toledo-Romaní, et al.
Journal of Clinical Microbiology
|
May 25, 2016
Correction for van Tonder et al., Genomics Reveals the Worldwide Distribution of Multidrug-Resistant Serotype 6E Pneumococci
Andries J van Tonder, James E Bray, Lucy Roalfe, et al.
Page
of 25